Men with localized, low-risk prostate cancer should be closely monitored until disease progression warrants treatment, concluded an independent panel of the National Institutes of Health.
13 Dec 2011
Routine prostate-specific antigen (PSA) screening of all men over a certain age began about 20 years ago, but the certainty about whether that was or is wise medical practice is long gone.
1 Jul 2011
This column reviews details on recent recalls, warnings, and approvals.
1 Jan 2021
The amount of absolute benefit from surgery depended on the baseline risk defined by extracapsular extension and a Gleason score higher than 7, according to long-term follow-up data from a Scandinavian study.
18 Dec 2018
Readers respond to the ACP Internist cover story that questioned the value of the annual physical exam. Whether they are for or against the practice, their opinions are strongly held.
1 Mar 2010
An integrated model of curative and palliative care may lead some physicians to reconsider their role in care at the end of life.
1 Jul 2018
This column reviews details on recent recalls, alerts, and approvals.
1 Sep 2021
A 68-year-old man is evaluated at a follow-up appointment. He has a 7-year history of heart failure secondary to ischemic cardiomyopathy. Over the past 6 months, he has had three hospitalizations for exacerbations of his heart failure. He currently has exertional dyspnea while getting dressed, and his maximal activity level is limited to riding to the store with his wife but staying in the car. Following a physical exam and lab studies, what is the most appropriate management?
13 Mar 2018
Clinicians should talk to men ages 55 to 69 about the potential benefits and harms of screening, according to the U.S. Preventive Services Task Force. For men ages 70 years and older, the potential benefits of prostate-specific antigen (PSA)-based screening do not outweigh the harms, the Task Force said.
18 Apr 2017
Documentation of informed consent is an important deterrent to malpractice and negligence claims. One physician describes how his informed consent process was the deciding factor in a missed case of prostate cancer, and outlines how any physician can accomplish it.
1 Jan 2012